Findings strongest for youngest patients with incident asthma treated in routine care.
Short-term high-dose inhaled or systemic corticosteroid use does not appear to correlate with increased adverse events across organ systems in children aged ≤6 years.
Endobronchial brush samples from individuals with T2-low inflammation had significantly more fungal diversity compared with those with T2-high inflammation.
Patients with asthma and/or chronic obstructive pulmonary disease have an increased risk for the development of long-term lower back pain.
Better family ties linked to improved management, outcomes in dangerous/disorderly neighborhoods.
With 1 year of use, improvements seen in asthma outcomes.
Burden of new pediatric asthma cases accounts for 13% of global incidence.
Genetic evidence shows elevated SHBG levels may protect against asthma, mostly in females.
Omega fatty acid intake also modifies effect of indoor PM exposure on respiratory symptoms
People living in homes with high average air exchange rates are more likely to report chronic cough, asthma, or asthma-like symptoms..
A new electronic decision support tool can improve the quality of asthma care in primary care settings.
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.
Overweight/obese teens, young adults taking supplements do not have improved asthma control.
Odds of being undiagnosed higher for girls, Asian-Americans vs white non-Hispanics.
The combined use of mometasone furoate and formoterol in adults and adolescents with persistent asthma may not increase asthma-related adverse events and may reduce the risk of worsening asthma outcomes.
Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.
Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.
Bronchoscopic lung volume reduction with valve replacement shows the most promise for improving lung function, exercise tolerance, and quality of life in patients with advanced emphysema.
Gaps in insurance coverage increased the odds of asthma-related emergency department intervention or hospitalization and exacerbations.
Facilitator-led sites had a higher percentage of patients who reported equal participation with their provider in making asthma treatment decisions vs the lunch-and-learn sites.